Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

Snowdrops always catch us by surprise. In the bleakest month their green leaves push up through brown leaf litter or through ...

点击“蓝字”关注我们编者按：IgA肾病（IgAN）是全球最常见的原发性肾小球疾病，其发病机制复杂且临床病程多变。近年来，补体系统激活作为IgA肾病进展的关键驱动因素被广泛关注，推动了补体靶向治疗的快速发展。近期，国际权威期刊Kidney ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A ...

OSE will now pivot to focus on the late-stage development of its cancer vaccine, Tedopi and its anti-inflammatory drug, ...

The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at ...

Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...

Glycosylation research is steadily emerging as a critical area in the field of tumor immunology, offering fresh insights into how cancers subvert immune ...

Topline results from the MUSCLE study indicate that ulviprubart did not meet its primary endpoint of mean change in inclusion body myositis functional rating scale scores.

Fire blight remains one of the most destructive bacterial diseases threatening global apple production, with limited long-term control options. A new ...

Siglecs are sialic-acid-binding immunoglobulin-like lectins that are mostly expressed by cells of the immune system. Siglecs can be divided into two subsets based on their sequence similarity and ...

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...